Robinson Value Management Ltd. Purchases 523 Shares of The Clorox Company (NYSE:CLX)

Robinson Value Management Ltd. lifted its position in shares of The Clorox Company (NYSE:CLX) by 4.7% in the fourth quarter, HoldingsChannel.com reports. The fund owned 11,539 shares of the company’s stock after buying an additional 523 shares during the period. Robinson Value Management Ltd.’s holdings in Clorox were worth $1,874,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. State Street Corp increased its position in Clorox by 3.1% during the 3rd quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after purchasing an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC increased its position in Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after purchasing an additional 4,490,421 shares in the last quarter. Geode Capital Management LLC increased its position in Clorox by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after purchasing an additional 33,970 shares in the last quarter. Stifel Financial Corp increased its position in Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock worth $380,370,000 after purchasing an additional 37,967 shares in the last quarter. Finally, Van ECK Associates Corp increased its position in Clorox by 2.2% during the 3rd quarter. Van ECK Associates Corp now owns 1,492,717 shares of the company’s stock worth $237,372,000 after purchasing an additional 31,510 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Price Performance

Shares of CLX opened at $148.51 on Friday. The firm has a market cap of $18.38 billion, a PE ratio of 40.58, a price-to-earnings-growth ratio of 2.52 and a beta of 0.42. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.62 and a current ratio of 0.94. The business’s 50 day moving average price is $161.06 and its two-hundred day moving average price is $158.70.

Clorox (NYSE:CLX) last issued its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same quarter last year, the firm earned $2.16 EPS. On average, equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.29%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s payout ratio is 133.33%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the stock. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research report on Tuesday, February 4th. Evercore ISI upped their price objective on shares of Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Barclays upped their price objective on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a research report on Wednesday. TD Cowen raised shares of Clorox from a “sell” rating to a “hold” rating and raised their price target for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Finally, Wells Fargo & Company boosted their price objective on shares of Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $158.21.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.